Is Epstein–Barr virus present in the CNS of patients with MS?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Epidemiologic studies, including studies of identical twins, argue for an infectious cause of MS. There is evidence that the pathogenesis of MS might involve an age-dependent host response to Epstein–Barr virus (EBV) infection, because an association between delayed primary infection and MS was shown.1 Recently, a serologically based association between clinical disease activity and EBV reactivation in MS was described.2 Although the absence of EBV DNA sequences in serum from patients with MS had been reported before, additional studies to delineate further the role of EBV in reactivation in MS are warranted. Here we present the results of a study using a unique set of clinical specimens: CSF and paraffin-embedded active demyelinating MS brain lesions obtained at autopsy and CSF from patients with MS and control subjects collected during life to assess the presence of EBV DNA in these clinical specimens by PCR.
Clinical material.
Formalin-fixed, paraffin-embedded brain tissue specimens obtained at rapid autopsy were collected …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Association between clinical disease activity and Epstein–Barr virus reactivation in MSK.-P. Wandinger, W. Jabs, A. Siekhaus et al.Neurology, July 25, 2000 -
Article
Epstein-Barr virus in oral shedding of children with multiple sclerosisCarmen Yea, Raymond Tellier, Patrick Chong et al.Neurology, September 06, 2013 -
Articles
Current and past Epstein-Barr virus infection in risk of initial CNS demyelinationR.M. Lucas, A.-L. Ponsonby, K. Dear et al.Neurology, July 13, 2011 -
Articles
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosisS.A. Sargsyan, A.J. Shearer, A.M. Ritchie et al.Neurology, March 10, 2010